Cao L, Zhu G, Wang X, Kuang Z, Song X, Ma X
Front Oncol. 2024; 14:1326970.
PMID: 39035732
PMC: 11257841.
DOI: 10.3389/fonc.2024.1326970.
Mi J, Wang R, Han X, Ma R, Li H
Medicine (Baltimore). 2023; 102(48):e36228.
PMID: 38050202
PMC: 10695564.
DOI: 10.1097/MD.0000000000036228.
Fang J, Huang X, Chen X, Xu Q, Chai T, Huang L
Cancer Med. 2023; 12(16):17126-17138.
PMID: 37519112
PMC: 10501252.
DOI: 10.1002/cam4.6362.
Shigenobu T, Ohtsuka T, Hanawa R, Sakamaki H, Yoshizu A, Tajima A
Ann Thorac Cardiovasc Surg. 2023; 29(6):279-286.
PMID: 37316253
PMC: 10767656.
DOI: 10.5761/atcs.oa.23-00032.
Zhou H, Liu H, Li J, Wang J, Fu X, Li Y
Genes Genomics. 2023; 45(8):1037-1046.
PMID: 37306927
PMC: 10349697.
DOI: 10.1007/s13258-023-01412-7.
Breath Volatile Organic Compounds in Surveillance of Gastric Cancer Patients following Radical Surgical Management.
Skapars R, Gasenko E, Broza Y, Sivins A, Polaka I, Bogdanova I
Diagnostics (Basel). 2023; 13(10).
PMID: 37238155
PMC: 10216977.
DOI: 10.3390/diagnostics13101670.
Utility of PET Scans in the Diagnosis and Management of Gastrointestinal Tumors.
Menon N, Mandelkern M
Dig Dis Sci. 2022; 67(10):4633-4653.
PMID: 35908126
DOI: 10.1007/s10620-022-07616-3.
Association among prognostic nutritional index, post-operative infection and prognosis of stage II/III gastric cancer patients following radical gastrectomy.
Xiao Y, Wei G, Ma M, Liu D, Chen P, Quan H
Eur J Clin Nutr. 2022; 76(10):1449-1456.
PMID: 35354923
PMC: 9550621.
DOI: 10.1038/s41430-022-01120-7.
Impact of the time from the completion of neoadjuvant chemotherapy to surgery on the outcomes of patients with gastric cancer.
Wu C, Zhou H, Wang T, Zhang X, Chen Y, Zhao D
Transl Cancer Res. 2022; 8(5):1853-1862.
PMID: 35116936
PMC: 8798596.
DOI: 10.21037/tcr.2019.08.42.
Development of a predictive model for extragastric recurrence after curative resection for early gastric cancer.
Bae J, Chang W, Kim S, Choi Y, Kong S, Lee H
Gastric Cancer. 2021; 25(1):255-264.
PMID: 34291321
DOI: 10.1007/s10120-021-01217-1.
Risk of Second Primary Malignancies among Patients with Early Gastric Cancer Exposed to Recurrent Computed Tomography Scans.
Kim T, Lee Y, Min Y, Lee H, Min B, Lee J
Cancers (Basel). 2021; 13(5).
PMID: 33800037
PMC: 7962111.
DOI: 10.3390/cancers13051144.
Survival advantage of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) for advanced gastric cancer: experience from a Western tertiary referral center.
Rosa F, Galiandro F, Ricci R, Di Miceli D, Longo F, Quero G
Langenbecks Arch Surg. 2021; 406(6):1847-1857.
PMID: 33704561
PMC: 8481141.
DOI: 10.1007/s00423-021-02102-2.
Survival advantage of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC) for advanced gastric cancer: experience from a Western tertiary referral center.
Rosa F, Galiandro F, Ricci R, Di Miceli D, Longo F, Quero G
Langenbecks Arch Surg. 2021; 406(4):1071-1080.
PMID: 33611693
PMC: 8208915.
DOI: 10.1007/s00423-021-02137-5.
Clinic image surveillance reduces mortality in patients with primary hepato-gastrointestinal cancer who develop second primary lung cancer: A STROBE-compliant retrospective study.
Huang H, Lu M, Chen M, Chang H, Kuo C, Lin S
Medicine (Baltimore). 2020; 99(50):e23440.
PMID: 33327274
PMC: 7738109.
DOI: 10.1097/MD.0000000000023440.
Association Among Blood Transfusion, Postoperative Infectious Complications, and Cancer-Specific Survival in Patients with Stage II/III Gastric Cancer After Radical Gastrectomy: Emphasizing Benefit from Adjuvant Chemotherapy.
Xiao H, Xiao Y, Chen P, Quan H, Luo J, Huang G
Ann Surg Oncol. 2020; 28(4):2394-2404.
PMID: 32929601
PMC: 7940152.
DOI: 10.1245/s10434-020-09102-4.
Deep sequencing of circulating tumor DNA detects molecular residual disease and predicts recurrence in gastric cancer.
Yang J, Gong Y, Lam V, Shi Y, Guan Y, Zhang Y
Cell Death Dis. 2020; 11(5):346.
PMID: 32393783
PMC: 7214415.
DOI: 10.1038/s41419-020-2531-z.
Surveillance and outcomes after curative resection for gastroesophageal adenocarcinoma.
Jiang D, Suzuki C, Espin-Garcia O, Lim C, Ma L, Sun P
Cancer Med. 2020; 9(9):3023-3032.
PMID: 32130793
PMC: 7196047.
DOI: 10.1002/cam4.2948.
SEOM clinical guideline for the diagnosis and treatment of gastric cancer (GC) and gastroesophageal junction adenocarcinoma (GEJA) (2019).
Martin-Richard M, Carmona-Bayonas A, Custodio A, Gallego J, Jimenez-Fonseca P, Reina J
Clin Transl Oncol. 2020; 22(2):236-244.
PMID: 31989475
DOI: 10.1007/s12094-019-02259-9.
PTK-7 Expression in Gastric Cancer: A Prognostic Determinant.
Ozcelik M, Ercelep O, Keser S, Barisik N, Basar M, Odabas H
Balkan Med J. 2019; 37(2):91-97.
PMID: 31820857
PMC: 7094185.
DOI: 10.4274/balkanmedj.galenos.2019.2019.8.12.
Preoperative Nodal F-FDG Avidity Rather than Primary Tumor Avidity Determines the Prognosis of Patients with Advanced Gastric Cancer.
Kwon H, An L, Kwon H, Park S, Kim S
J Gastric Cancer. 2018; 18(3):218-229.
PMID: 30275999
PMC: 6160526.
DOI: 10.5230/jgc.2018.18.e23.